VSE

What this means for you

Not registered yet, but its 01 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98429879

Mark type

Stylized text

Filed

01 Mar 2024

Attorney of record

Nicole K. McLaughlin

Goods and services

• Class 001 — Chemicals: Cell culture reagents for laboratory use, namely, for research use; cell culture reagents for scientific and research purposes; antibody reagents for scientific purposes; diagnostic reagents for medical-scientific research use; chemical preparations for the use in the production of medicines; chemical preparations for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; biochemical preparations for scientific purposes; catalysts in the nature of small molecules for use in increasing viral yield for use in the manufacture of vaccines and viral medicines; chemical and biochemical preparations for scientific use, research use, and laboratory research use; chemical and biochemical preparations for scientific use and for scientific research use; reagents for scientific and research use, in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses, and pseudo-viral particles; chemical and biochemical preparations, agents, and reagents sold as a unit for producing viruses using transfection for scientific use and for scientific research use
• Class 040 — Treatment of materials: Biological production, namely, custom manufacture of biological preparations in the field of gene therapy and cell therapies; biological production, namely, custom manufacture of biological preparations in the field of vaccines
• Class 042 — Scientific and technological services: scientific research and analysis for scientific research purposes in the field of gene and cell therapies; scientific research and analysis for scientific research purposes in the field of vaccines; research and development in the field of vaccines; testing services in the field of vaccines; laboratory research in the field of gene expression; research in the field of gene therapy; research and development in the medical biotechnology field; development of biotechnology; research and development in the pharmaceutical and biotechnology fields

Owner

• Virica Biotech Inc., Ottawa, Ontario, CA

Prosecution history

• 21 Jan 2026 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
• 21 Jan 2026 — INQUIRY TO SUSPENSION E-MAILED
• 21 Jan 2026 — SUSPENSION INQUIRY WRITTEN
• 18 Jan 2026 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
• 17 Jul 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 17 Jul 2025 — LETTER OF SUSPENSION E-MAILED
• 17 Jul 2025 — SUSPENSION LETTER WRITTEN
• 17 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 17 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 15 Jul 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
• 12 Jun 2025 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
• 12 Jun 2025 — INQUIRY TO SUSPENSION E-MAILED
• 12 Jun 2025 — SUSPENSION INQUIRY WRITTEN
• 12 Jun 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
• 11 Dec 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED